
浏览全部资源
扫码关注微信
1.安徽中医药大学 研究生院,合肥 230001
2.安徽中医药大学 第一附属医院,合肥 230031
吴梦婷,在读硕士,从事中西医结合防治脑病研究,E-mail:975083182@qq.com
董婷,博士,主任医师,博士生导师,从事中医药防治神经变性疾病研究,Tel:0551-62838522,E-mail:876786557@qq.com
收稿日期:2022-06-26,
网络出版日期:2022-08-16,
纸质出版日期:2022-12-05
移动端阅览
吴梦婷,董婷,赵晨玲等.基于数字化目诊信息探讨肝豆灵联合短期驱铜治疗对肝豆状核变性肝型患者的临床疗效[J].中国实验方剂学杂志,2022,28(23):103-109.
WU Mengting,DONG Ting,ZHAO Chenling,et al.Gandouling Combined with Short-term Copper-expelling Therapy in Patients with Hepatic Wilson's Disease Based on Digital Diagnosis Information on Eyes[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(23):103-109.
吴梦婷,董婷,赵晨玲等.基于数字化目诊信息探讨肝豆灵联合短期驱铜治疗对肝豆状核变性肝型患者的临床疗效[J].中国实验方剂学杂志,2022,28(23):103-109. DOI: 10.13422/j.cnki.syfjx.20222391.
WU Mengting,DONG Ting,ZHAO Chenling,et al.Gandouling Combined with Short-term Copper-expelling Therapy in Patients with Hepatic Wilson's Disease Based on Digital Diagnosis Information on Eyes[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(23):103-109. DOI: 10.13422/j.cnki.syfjx.20222391.
目的
2
开展数字化目诊信息研究,探讨肝豆状核变性[又称Wilson病(WD)]肝型患者目络特征及肝豆灵(GDL)干预研究,以期为肝豆灵治疗WD肝型患者的临床疗效提供参考。
方法
2
收集82例WD肝型患者(WD组)和健康志愿者68例[正常组(NC组)]。所有受试者均应用目诊仪采集眼部图像,进行目络特征的数字化提取。分析WD组的重要目络特征与NC组之间的差异。采用Pearson相关性检验分析探讨WD肝型患者目络特征与肝损害血清学指标[丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、白蛋白(ALB)]水平及Child-Pugh评分的相关性。将82例WD肝型患者随机分为观察组(42例)和对照组(40例),对照组给予二巯丙磺钠(DMPS)治疗,观察组在西医治疗基础上加用中药肝豆灵片,共6个疗程(8 d为1个疗程)。评估肝豆灵干预治疗对ALT、AST、ALB水平及目络特征积分和Child-Pugh评分的影响。
结果
2
①与NC组比较,WD组在目络特征“丘”(
P
<
0.05)和“血脉”(
P
<
0.05)积分更高。②WD肝型患者的ALT、AST水平、Child-Pugh评分与目络特征“丘”和“血脉”积分呈正相关,ALB水平与目络特征“丘”和“血脉”积分呈负相关。③与治疗前比较,两组患者血清ALT、AST水平、Child-Pugh评分及目络特征“丘”和“血脉”积分均显著降低(
P<
0.01)
,
ALB水平均显著上升(
P<
0.01)。④与对照组治疗后比较,观察组ALT、ALB水平及目络特征“丘”和“血脉”积分明显改善(
P<
0.05);观察组Child-Pugh评分显著改善(
P<
0.01);AST组间比较差异无统计学意义。
结论
2
与正常人比较,WD肝型患者的目络特征在“丘”和“血脉”上积分更高,代表WD肝型患者以湿、热征象为主,且“丘”和“血脉”积分与肝损害严重程度呈正相关。同时,在西医驱铜治疗基础上,联合中药肝豆灵可显著改善WD患者的肝功能,提高临床疗效。
Objective
2
To explore the characteristics of eye collaterals of patients with hepatic Wilson's disease (WD) and intervention effect of Gandouling (GDL) based on digital diagnosis information on eyes, in order to provide references for the clinical efficacy of GDL in the treatment of patients with hepatic WD.
Method
2
Eighty-two patients with hepatic WD (WD group) and 68 healthy volunteers (normal control group, NC) were enrolled. Eye images of all subjects were collected by the ophthalmoscope, followed by digital extraction of eye collateral characteristics. Differences in main eye collateral characteristics between the WD group and the NC group were analyzed. Pearson correlation test was used to analyze the eye collateral characteristics, serological indexes of liver damage [alanine aminotransferase (ALT),aspartate transaminase (AST),and albumin (ALB)], and Child-Pugh score in patients with hepatic WD. The 82 patients with hepatic WD were divided into a treatment group (42 cases) and a control group (40 cases). All patients were treated with sodium 2,3-dimercapto-1-propane sulfonate (DMPS), while those in the treatment group received additional GDL Tablets. One course of treatment contained eight days, and the treatment lasted six courses. The effects of GDL intervention on the levels of ALT,AST, and ALB,as well as the eye collateral characteristics score and Child-Pugh score were evaluated.
Result
2
① Compared with the NC group,the WD group had higher scores of "Qiu" (
P
<
0.05) and "Xuemai"
(
P
<
0.05),which are the characteristics of eye collaterals. ② The levels of ALT and AST, and Child-Pugh score in patients with hepatic WD were positively correlated with the scores of "Qiu" and "vessel",while the ALB level was negatively correlated with the "bulge" and "Xuemai" scores. ③ Compared with the conditions before treatment,the serum ALT and AST levels,Child-Pugh score,and the "Qiu" and " Xuemai " scores of the two groups were reduced
(
P
<
0.01),and the ALB levels were increased (
P
<
0.01). ④ Compared with the control group after treatment,the treatment group showed improved levels of ALT and ALB and the scores of "Qiu" and "Xuemai"
(
P
<
0.05)and better Child-Pugh score
(
P
<
0.01). There was no significant difference in AST between the two groups.
Conclusion
2
Compared with healthy people,hepatic WD patients showed higher scores of "Qiu" and "Xuemai", indicating that patients with hepatic WD were mainly characterized by dampness and heat,and the scores of "Qiu" and "Xuemai" were positively correlated with the severity of liver damage. Meanwhile,copper-expelling therapy combined with GDL can significantly improve the liver function of WD patients and improve the clinical efficacy.
CHAUDHRY H S , ANILKUMAR A C . Wilson disease [M]. Treasure Island : StatPearls , 2022 .
BANDMANN O , WEISS K H , KALER S G . Wilson's disease and other neurological copper disorders [J]. Lancet Neurol , 2015 , 14 ( 1 ): 103 - 113 .
XIE J J , WU Z Y . Wilson's disease in China [J]. Neurosci Bull , 2017 , 33 ( 3 ): 323 - 330 .
KANNAUJE P K , PANDIT V R , WASNIK P N , et al . Wilson's disease: Diagnosis in novel way [J]. Cureus , 2021 , 13 ( 10 ): e18650 .
KASZTELAN-SZCZERBINSKA B , CICHOZ-LACH H . Wilson's disease:An update on the diagnostic workup and management [J]. J Clin Med , 2021 , 10 ( 21 ): 5097 .
XIAO Q Q , FAN J G . Advances in the treatment of Wilson disease [J]. Chin J Hepatol , 2021 , 29 ( 1 ): 79 - 82 .
陈永华 , 杨文明 , 汪瀚 , 等 . 杨文明关于肝豆状核变性辨治思路及经验撷菁 [J]. 中华中医药杂志 , 2020 , 35 ( 4 ): 1843 - 1846 .
XU M B , RONG P Q , JIN T Y , et al . Chinese herbal medicine for Wilson's disease: A systematic review and Meta-analysis [J]. Front Pharmacol , 2019 , 10 : 277 .
文愈龙 , 刘毅 .“ 脏腑-膜原(玄府)-眼目”气血输布轴探讨 [J]. 中华中医药杂志 , 2021 , 36 ( 11 ): 6818 - 6820 .
胡平会 , 魏伟 , 孙化萍 . 试以“五轮学说”阐析视疲劳 [J]. 中华中医药杂志 , 2019 , 34 ( 7 ): 2923 - 2925 .
陈永华 , 杨文明 , 张波 , 等 . 解毒化瘀方肝豆灵片治疗肝豆状核变性的临床疗效观察 [J]. 中华中医药杂志 , 2019 , 34 ( 1 ): 390 - 393 .
陈永华 , 杨文明 , 江海林 , 等 . 肝豆灵片对硫酸铜模拟铜负荷诱导TX小鼠原代肝细胞凋亡的影响 [J]. 中成药 , 2019 , 41 ( 3 ): 672 - 675 .
中华医学会神经病学分会帕金森病及运动障碍学组 , 中华医学会神经病学分会神经遗传病学组 . 肝豆状核变性的诊断与治疗指南 [J]. 中华神经科杂志 , 2008 ( 8 ): 566 - 569 .
王金觉 . 《望目辨证诊断学》 [M]. 北京 : 中国中医药出版社 , 2013 .
TSORIS A , MARLAR C A . Use of the Child Pugh score in liver disease [M]. Treasure Island : StatPearls , 2022 .
CHEN Y C , YU H , WANG R M , et al . Contribution of intragenic deletions to mutation spectrum in Chinese patients with Wilson's disease and possible mechanism underlying ATP7B gross deletions [J]. Parkinsonism Relat Disord , 2019 , 62 : 128 - 133 .
SHRIBMAN S , POUJOIS A , BANDMANN O , et al . Wilson's disease:Update on pathogenesis,biomarkers and treatments [J]. J Neurol Neurosurg Psychiatry , 2021 , 92 ( 10 ): 1053 - 1061 .
COLLINS C J , YI F , DAYUHA R , et al . Direct measurement of ATP7B peptides is highly effective in the diagnosis of Wilson disease [J]. Gastroenterology , 2021 , 160 ( 7 ): 2367 - 2382 .
鲍远程 , 杨文明 , 张波 , 等 . 现代中医神经病学 [M]. 北京 : 人民卫生出版社 , 2003 : 517 - 530 .
张安玲 . 肝风概念、病机与证候探讨 [J]. 中国中医急症 , 2004 , 13 ( 1 ): 27 - 28 .
杨文明 , 陈彪 , 鲍远程 , 等 . 肝豆状核变性病中医临床思考 [J]. 中国实验方剂学杂志 , 2004 , 10 ( 6 ): 66 - 69 .
钱南南 , 杨文明 , 魏涛华 , 等 . 肝豆状核变性伏毒阻络病因病机探要 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 12 ): 133 - 140 .
钱南南 , 杨文明 , 魏涛华 , 等 . 肝豆状核变性伏毒阻络病因病机探要 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 12 ): 133 - 140 .
唐露露 , 杨文明 , 董婷 , 等 . 肝豆扶木颗粒治疗肝肾亏虚兼痰瘀互结型Wilson病患者的临床疗效 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 12 ): 127 - 132 .
杨文明 , 韩辉 , 鲍远程 , 等 . 中医对肝豆状核变性病因病机及辨证论治的探索 [J]. 北京中医药大学学报:中医临床版 , 2012 , 19 ( 4 ): 6 - 9 .
陈震霖 , 张硕 , 张景明 , 等 . 论中医整体观的基本特性 [J]. 中国中医基础医学杂志 , 2021 , 27 ( 9 ): 1348 - 1351 .
张赫怡 , 刘巍 , 邢文龙 , 等 . 中医目诊理论发展与临床应用现状 [J]. 北京中医药 , 2021 , 40 ( 10 ): 1165 - 1168 .
朱会明 , 贾微 , 刘平 , 等 . 传统目诊理论及技术的现代应用与发展 [J]. 中华中医药杂志 , 2018 , 33 ( 2 ): 635 - 637 .
朱会明 , 赵锐 , 高悦 , 等 . 基于图像识别技术的中医肝病目诊系统设计与研发 [J]. 世界中医药 , 2020 , 15 ( 10 ): 1494 - 1497 .
沈同平 , 胡纪源 , 马春 , 等 . 国内肝豆状核变性研究进展可视化分析 [J]. 河北北方学院学报:自然科学版 , 2020 , 36 ( 1 ): 27 - 32 .
杨文明 , 赵广峰 , 董婷 , 等 . 治疗肝豆状核变性中医药研究进展 [J]. 中国实验方剂学杂志 , 2008 , 14 ( 2 ): 71 - 73 .
郝文杰 , 杨文明 , 魏涛华 , 等 . 基于“肝络微癥积”学说探讨中医药抗肝豆状核变性肝纤维化治疗策略 [J]. 北京中医药大学学报 , 2022 , 45 ( 3 ): 307 - 312 .
杨任民 . 肝豆状核变性的中西医结合治疗 [J]. 中国中西医结合杂志 , 2007 , 27 ( 9 ): 773 - 775 .
ZHANG J , XIE D , LI Y , et al . Evaluation of efficacy and safety of gandouling plus sodium dimercaptosulphonate in treatment of patients with neurological Wilson's disease from China [J]. J Tradit Chin Med , 2018 , 38 ( 5 ): 781 - 786 .
ZHANG J , TANG L L , LI L Y , et al . Gandouling tablets inhibit excessive mitophagy in toxic milk (TX) model mouse of Wilson Disease via Pink1/Parkin pathway [J]. Evid Based Complement Alternat Med , 2020 , 2020 : 3183714 .
马守亮 , 蔡永亮 , 徐磊 , 等 . 多烯磷脂酰胆碱联合肝豆灵片治疗肝型肝豆状核变性32例 [J]. 中医药临床杂志 , 2012 , 24 ( 3 ): 207 - 208 .
0
浏览量
22
下载量
4
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621